Efficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to observe the clinical efficacy and safety of Durvalumab
combined with intrathecal chemotherapy in non-small cell lung cancer with leptomeningeal
metastasis